Purpose: To determine the rate of complications associated with a port-catheter
system implanted via the femoral arterial access for hepatic arterial chemotherapeutic
infusion.
Materials and Methods: One-hundred thirteen patients with liver metastases and
primary hepato-biliarypancreatic tumors underwent the procedure. The infusion catheter
was connected to a port implanted subcutaneously below the level of the inguinal
ligament.
Results: Implantation of the system was successful in 107 of 113 patients (94.7%). We
did not treat with infusion chemotherapy on 5 of 107 patients because of poor general
condition. The observation period after placement ranged from 4 to 787 days (mean 233
days). Complications after system placement were observed in 18 of 102 patients (17.6%),
These included hepatic arterial injury (7.8%) with a mean system use of 361 days (range
24-671 days), pocket trouble (4.9%) with a mean ,system use of 253 days (range 21-624
days), port-catheter system obstruction (3.9%) with a mean system use of 100 days
(range 62-263 days) and significant catheter dislodgement from the target artery (2.9%)
with a mean system use of 384 days (range 358-436 days).
Conclusion: Our data suggested that it was feasible and safe to place the port-catheter
system percutaneously via the femoral artery.
Complications Encountered with a Transfemorally Placed Port-Catheter system for Regional Chemotherapy of Hepatobiliary-Pancreatic Tumors
akigaku31-34h.pdf
(471.02KB)
